What is chronic kidney disease (CKD)?
什么是慢性肾脏疾病（CKD）?。
The TCM pathogenesis of CKD is complicated.
本病的中医发病机制复杂。
If untreated, CKD can result in kidney failure.
如果不经治疗，CKD能导致肾功能衰竭。
The prevalence of CKD was higher in female and increased with age.
女性CKD患病率高于男性，并随年龄增长而上升。
Conclusions: Renal Function decreased significantly in Hospitalized CKD patients.
结论：住院CKD患者肾功能下降显著。
Arterial hypertension and dyslipidemia in patients with chronic kidney disease (CKD).
慢性肾脏病(CKD)患者动脉高血压和血脂异常。
So can you discuss a little bit about the treatment of hypertensive patients with CKD?
请您谈谈对合并慢性肾病的高血压患者的治疗。
CKD diagnosis has been confirmed for every patient either by pathological or clinical method.
所有患者均经病理诊断或临床确诊，且均符合CKD的诊断标准。
Lower BMI is associated with greater mortality in patients with CKD not yet on dialysis therapy.
结论：有较低体重指数尚未接受透析治疗的慢性肾脏疾病（CKD）患者有高的死亡率。
Scientists are continually looking for new ways to treat CKD and stop kidneys from deteriorating.
科学家正在不遗余力的寻找治疗CKD和阻止肾脏退化的方法。
Background: Atherosclerosis and hypertension has been known to relate to chronic kidney disease (CKD).
背景：众所周知，动脉粥样硬化和高血压与慢性肾脏病(CKD)有关。
These findings could lead to earlier diagnosis and treatment of phosphate problems in people with CKD.
这些发现可能促进CKD患者更早诊断和治疗磷酸盐代谢障碍。
Hypertension or high blood pressure is a major risk factor for people with chronic kidney disease (CKD).
高血压或血压升高是慢性肾病(CKD)患者的主要危险因子。
Various subgroups, including those based on different stages of CKD, showed consistent treatment effects.
各亚组，包括慢性肾脏病的不同阶段，显示一致的治疗效果。
Patients with documented CKD achieved treatment goals more frequently than patients without documented CKD.
证实慢性肾病的病人比未证实的病人更容易达到治疗目标。
Chronic Kidney disease (CKD) is clinically common and refractory disease, its morbidity is increasing year by year.
慢性肾脏病是临床常见、疑难疾病，其发病率正呈逐年上升趋势。
The goal of this review was to determine the effects of ESA treatment on clinical outcomes in patients with anemia and CKD.
这篇综述的目的是的目的是确定在贫血和慢性肾病患者中使用ESAs的治疗效果。
CKD can be caused by various diseases, like diabetes, high blood pressure, heart disease, infections or even physical injury.
CKD可以由各种不同的疾病引起，比如糖尿病、高血压、心脏病、传染甚至物理损伤。
Objective To observe and compare the oxidative stress in patients with chronic kidney diseases (CKD) of different clinical stages.
目的观察和比较慢性肾脏病(CKD)不同临床分期患者的氧化应激状态。
CKD is difficult to treat, and many patients progress to end-stage kidney disease and have to have dialysis or a kidney transplant.
CKD难以治疗，许多患者进展至终末期肾病，并且不得不接受透析或肾移植。
Nowadays the incidence of chronic kidney disease (CKD) is increasing. It is still not clear in China though it is about 11% in USA.
近年来慢性肾脏病(CKD)的发病率在逐年升高，美国的发病率为11%，我国的发病率仍不清楚。
This study sought to determine the association among MDC, survival, and risk for hospitalization among elderly outpatients with CKD.
该研究试图确定老年CKD患者MDC、生存率和需住院治疗风险率之间的相关性。
We investigated the impact of antihypertensive drug to prevent CKD incidence in hypertensive patients with advanced atherosclerosis.
我们研究了在高血压合并晚期动脉粥样硬化患者中抗高血压药物对预防CKD的影响。
Traditional risk factors can not fully explain the high incidence of cardiovascular disease in chronic kidney disease (CKD) patients.
心血管传统危险因素已不能完全解释慢性肾脏病(CKD)患者心血管疾病的高发率。
Conclusion It is the key point to prevent AKI that pay more attention to control and intervene the risk factors of elder CKD patients.
结论重视老年慢性肾脏病患者高危因素的控制和积极干预，是预防其发生急性肾损伤的关键。
A majority of CKD patients actually die from cardiovascular complications that arise from the high blood pressure associated with kidney malfunction.
大多数CKD患者实际死于心血管病发证，这些并发症是由于高血压伴肾功能紊乱引发的。
Is Angiotensin-Converting Enzyme Inhibitor and Angiotensin Receptor Blocker Combination therapy Better Than Monotherapy and Safe in Patients With CKD?
血管紧张素转化酶抑制剂和血管紧张素受体拮抗剂联合用药治疗CKD是否比单药应用要好？
Is Angiotensin-Converting Enzyme Inhibitor and Angiotensin Receptor Blocker Combination therapy Better Than Monotherapy and Safe in Patients With CKD?
血管紧张素转化酶抑制剂和血管紧张素受体拮抗剂联合用药治疗CKD是否比单药应用要好？
应用推荐